Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at H.C. Wainwright
Overview - The company is a broad-based RNAi (RNA interference) firm that has developed the capability to target various cell types and diseases [3] Pipeline and Therapeutic Areas - The company has a large pipeline of potential drug candidates but acknowledges that not all can be commercialized, leading to a strategy focused on licensing and partnerships [3]